Your browser doesn't support javascript.
loading
IMPLICATIONS OF GLOBAL PRICING POLICIES ON ACCESS TO INNOVATIVE DRUGS: THE CASE OF TRASTUZUMAB IN SEVEN LATIN AMERICAN COUNTRIES.
Pichon-Riviere, Andres; Garay, Osvaldo Ulises; Augustovski, Federico; Vallejos, Carlos; Huayanay, Leandro; Bueno, Maria del Pilar Navia; Rodriguez, Alarico; de Andrade, Carlos José Coelho; Buendía, Jefferson Antonio; Drummond, Michael.
Afiliação
  • Pichon-Riviere A; IECS - Institute for Clinical Effectiveness and Health Policy;School of Public Health,University of Buenos Airesapichon@iecs.org.ar.
  • Garay OU; IECS - Institute for Clinical Effectiveness and Health Policy.
  • Augustovski F; IECS - Institute for Clinical Effectiveness and Health Policy;School of Public Health,University of Buenos Aires.
  • Vallejos C; Universidad de La Frontera.
  • Huayanay L; Universidad Peruana Cayetano Heredia.
  • Bueno Mdel P; Universidad de San Andrés.
  • Rodriguez A; Fondo Nacional de Recursos (FNR).
  • de Andrade CJ; Brazilian National Cancer Institute-INCA.
  • Buendía JA; Department of Pharmacology,School of Medicine,University of Antioquia.
  • Drummond M; Centre for Health Economics,University of York.
Int J Technol Assess Health Care ; 31(1-2): 2-11, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25989703
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Custos e Análise de Custo / Trastuzumab / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Custos e Análise de Custo / Trastuzumab / Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article